Skip to content

Improving Sleep Health in Adults With Overweight or Obesity

A Behavioral Intervention to Improve the Sleep Health of Adults With Obesity: A Feasibility and Acceptability Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04990206
Enrollment
19
Registered
2021-08-04
Start date
2021-10-07
Completion date
2022-09-21
Last updated
2022-09-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sleep Disturbance, Sleep Wake Disorders, Sleep Disorder

Brief summary

This study will examine the feasibility and acceptability of the Transdiagnostic Intervention for Sleep and Circadian Dysfunction (TranS-C) in adults with poor sleep and excess weight. Additionally, the study will explore if TranS-C improves sleep health and cardiovascular outcomes.

Detailed description

Aim 1 (Primary): Examine the feasibility and acceptability of TranS-C among adults with poor sleep health and excess weight. Aim 2 (Exploratory): Explore the effect of TranS-C on the sleep health of adults with poor sleep and excess weight. Aim 3 (Exploratory): Explore the effect of TranS-C on the cardiometabolic health of adults with poor sleep and excess weight.

Interventions

BEHAVIORALTranS-C

TranS-C will be provided in eight weekly, one-on-one 50-minute sessions delivered remotely by two-way video conferencing. Each week will include goal setting and homework assignments which will be reviewed in the following session. The sessions will include information on sleep and circadian rhythms, behavioral change and motivation, and goal setting. The topics covered in the sessions include establishing regular sleep-wake times, learning a wind-down route, learning a wake-up routine, improving daytime functioning, correcting unhelpful sleep-related beliefs, and maintenance of behavior change.

Sponsors

University of Pittsburgh
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Currently own and regularly use a smart phone * Body mass index \>27 and ≤ 43 * Poor sleep health on one or more of the sleep health dimensions

Exclusion criteria

* Presence of an unstable condition requiring physician-supervised diet and exercise * Physical limitations precluding ability to engage in moderate-intensity physical activity * Pregnant or intention to become pregnant during study * Current treatment for a serious mental illness * Being a current shift worker * Reported alcohol intake \> 4 drinks/day for males and \> 3 drinks/day for females * Current participation in a formal weight loss program, loss of ≥ 5% weight in past 6 months, or current use of weight loss medication * History of bariatric surgery * Planned extended vacations, absences, or relocation during study * Another member of household is a participant in the study * Score \> 32 on the Eating Habits Checklist, an eating disorder scale

Design outcomes

Primary

MeasureTime frameDescription
Recruitment rate6-monthsPercentage of potential participants screened in order to enroll 10 participants
Attrition rate6-monthsPercentage of enrolled participants completing the 8-week intervention
Completeness of questionnaire responses6-monthsPercentage of completed responses

Secondary

MeasureTime frameDescription
Change in alertness8-weeks (baseline to post-intervention)Change in Epworth Sleepiness Scale (ESS). Total score ranges from 0-24. Scores equal to or greater than 10 represent excessive daytime sleepiness.
Change in sleep timing8-weeks (baseline to post-intervention)Change in mean actigraphic sleep midpoint.
Change in sleep efficiency8-weeks (baseline to post-intervention)Change in mean actigraphic sleep efficiency.
Change in composite sleep health score8-weeks (baseline to post-intervention)Change in composite measure of sleep health which is the sum of scores on 6 sleep dimensions. Each dimension will be dichotomized as either 'good (1)' or 'poor (0)' based on clinically and scientifically relevant rationales and added together. Score will range from 0-6 with higher scores representing better sleep health.
Change in body mass index8-weeks (baseline to post-intervention)Calculated by dividing weight in pounds by height in inches squared and multiplying by a conversion factor of 703. Weight will be measured a with Tanita Scale and Body Fat Analyzer. Height will be measured in with a stadiometer.
Change in systolic and diastolic blood pressure (BP)8-weeks (baseline to post-intervention)Average of two blood pressure readings at least two minutes apart.
Change in waist circumference8-weeks (baseline to post-intervention)Measured with a Gulick II measuring tape above the right iliac crest. Will include two measurements to the nearest 0.1 cm. If the two values are within 2 cm of each other, a mean with be calculated; if not, the measurements will be repeated until they are within 2 cm of each other.
Change in sleep duration8-weeks (baseline to post-intervention)Change in mean actigraphic sleep duration.
Change in sleep regularity8-weeks (baseline to post-intervention)Change in standard deviation of actigraphic wake time.
Change in sleep satisfaction8-weeks (baseline to post-intervention)Change in Pittsburgh Sleep Quality Index (PSQI) sleep quality item. Item score ranges from 'very good (0)' to 'very bad (3)'.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026